Home/Filings/4/0001685556-26-000002
4//SEC Filing

Hakim Anat 4

Accession 0001685556-26-000002

CIK 0000059478other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:25 PM ET

Size

9.8 KB

Accession

0001685556-26-000002

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly (LLY) EVP Hakim Anat Exercises RSUs; Shares Withheld for Taxes

What Happened

  • Hakim Anat, EVP, General Counsel & Secretary of Eli Lilly (LLY), converted/exercised 6,700 restricted stock units (RSUs) on Feb 1, 2026. As part of the vesting/conversion, 2,953.395 shares were withheld to satisfy tax withholding obligations at a price of $1,037.15 per share, totaling $3,063,114. Net shares delivered to Anat were 3,746.605 (6,700 − 2,953.395). The filing shows the RSU conversion as derivative exercise (code M) and the withholding as a tax payment (code F).

Key Details

  • Transaction date: 2026-02-01; Form 4 filed: 2026-02-03 (appears timely).
  • RSUs converted: 6,700 shares (exercise/conversion code M, $0 exercise price).
  • Shares withheld for taxes: 2,953.395 shares at $1,037.15 each = $3,063,114 (code F).
  • Net shares retained after withholding: 3,746.605 shares.
  • Footnotes: F1 — Reporting person disclaims beneficial ownership except to extent of pecuniary interest; F2 — each restricted stock unit equals one share.
  • Filing does not list total shares owned after the transaction in the provided summary.

Context

  • This was a routine RSU vest/settlement with share withholding to cover taxes (a common non-market sale), not an open-market sale or independent purchase. The $3.06M figure reflects the value of shares withheld to meet tax obligations, not a discretionary sale indicating sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-01
Hakim Anat
EVP, GC & Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-01+6,70017,662.5 total
  • Tax Payment

    Common Stock

    2026-02-01$1037.15/sh2,953.395$3,063,11414,709.105 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F2]
    2026-02-016,7000 total
    From: 2026-02-01Exp: 2026-02-01Common Stock (6,700 underlying)
Holdings
  • Common Stock

    [F1]
    (indirect: By Anat Hakim SLAT)
    15,700
  • Common Stock

    [F1]
    (indirect: By Spouse)
    16,875
Footnotes (2)
  • [F1]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Signature
/s/ Jonathan Groff for Anat Hakim, pursuant to authorization on file|2026-02-03

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001685556

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:25 PM ET
Size
9.8 KB